Sphingolipid delta(4)-desaturase DES1

Summary
UniProt ID
O15121
Gene Symbol
  • DEGS1
  • DES1
  • MLD
Organism
Homo sapiens (human)
External Links
GlyGen
O15121
PubChem
O15121
SwissLipids
The O-GlcNAc Database
O15121
RaftProt
O15121
Annotation
Keyword
  • Disease variant
  • Endoplasmic reticulum
  • Fatty acid biosynthesis
  • Isomerase
  • Leukodystrophy
  • Mitochondrion
  • Myristate
  • Oxidoreductase
  • Phosphoprotein
  • Reference proteome
  • Transmembrane helix
Gene Ontology (GO)
Sequence
MGSRVSREDFEWVYTDQPHADRRREILAKYPEIKSLMKPDPNLIWIIIMMVLTQLGAFYIVKDLDWKWVIFGAYAFGSCINHSMTLAIHEIAHNAAFGNCKAMWNRWFGMFANLPIGIPYSISFKRYHMDHHRYLGADGVDVDIPTDFEGWFFCTAFRKFIWVILQPLFYAFRPLFINPKPITYLEVINTVAQVTFDILIYYFLGIKSLVYMLAASLLGLGLHPISGHFIAEHYMFLKGHETYSYYGPLNLLTFNVGYHNEHHDFPNIPGKSLPLVRKIAAEYYDNLPHYNSWIKVLYDFVMDDTISPYSRMKRHQKGEMVLE
Glycosylation Sites
Displaying 1 entry
Position Description PubMed ID GlyTouCan ID Source
Feature
  • ProtVista GlyGen : Glycosylation Site from GlyGen
  • ProtVista UniProt : Glycosylation Site from UniProt
Pathway
Displaying all 2 entries
Pathway Name Organism
Neutrophil degranulation Homo sapiens
Sphingolipid de novo biosynthesis Homo sapiens
Disease
Displaying entries 71 - 80 of 94 in total
DO ID Disease Name Source
DOID:4766 embryoma
DOID:4964 neurotic disorder
DOID:5041 esophageal cancer
DOID:543 dystonia
DOID:552 pneumonia
DOID:5672 large intestine cancer
DOID:574 peripheral nervous system disease
DOID:5844 myocardial infarction
DOID:5854 silent myocardial infarction
DOID:640 encephalomyelitis

About Release Notes Help Feedback

Click here to visit the beta site.


International Collaboration

GlyCosmos is a member of the GlySpace Alliance together with GlyGen and Glycomics@ExPASy.

Acknowledgements

Supported by JST NBDC Grant Number JPMJND2204

Partly supported by NIH Common Fund Grant #1U01GM125267-01


Logo License Policies Site Map

Contact: support@glycosmos.org

This work is licensed under Creative Commons Attribution 4.0 International


GlyCosmos Portal v4.0.0

Last updated: August 19, 2024